-
A soft, stimulating scaffold supports brain cell development outside the body
Time of Update: 2023-02-02
It can be used not only to study the formation of human neural networks in vitro, but also to create implantable biohybrid BCIs that bind more seamlessly to a patient's brain tissue, improving its performance and reducing the risk of injury," said first author Christina Tringides, PhD, a former graduate student at Wyss and SEAS and now a postdoctoral researcher at ETH Zürich.
-
"DNA virus vaccines" can be used to stop viral infections
Time of Update: 2023-01-05
Rutgers scientists have developed a new way to stop viral infections: a so-called live, replicated, defective DNA virus vaccine that uses a compound called centanamycin to create a mutated virus for vaccine development.
-
Blood: Single-cell omics reveals multilayered molecular mechanisms of CLL acquired venetox resistance
Time of Update: 2023-01-04
To fully understand the mechanisms of clinical resistance in VEN, the researchers combined single-cell short-read and long-read RNA sequencing to reveal the previously unrecognized scale of genetic and epigenetic changes supporting acquired VEN resistance.
-
Lancet Haematol: Zebratinib is expected to be a new option for patients with B-cell malignancies who were previously intolerant to BTK
Time of Update: 2023-01-04
This is an ongoing, multicenter, open-label, single-arm Phase 2 clinical trial to evaluate whether zebratinib can prolong treatment in previously treated patients with B-cell malignancies by minimizing treatment-related toxicity and discontinuation.
-
Effect of "new and old" actin on cell motility
Time of Update: 2022-11-04
A new study in the journal Nature provides a high-resolution structure showing how two key biochemical states of actin work with bending forces to determine how actin interacts with other proteins.
-
One case of acute B-lymphoblastic leukemia with BCR-ABL1
Time of Update: 2022-11-04
preface Acute lymphoblastic leukemia (ALL) is a type of acute leukemia that mainly originates from B or T line lymphoid progenitor cells, which abnormally proliferate and aggregate in the bone marrow,
-
The IRd regimen helps patients with cytogenetic high-risk MM to achieve lasting remission, with 1q21 amplification case analysis
Time of Update: 2022-10-20
Multiple myeloma (MM) is a malignant disease in which clonal plasma cells proliferate abnormally, often in old age. Patients with MM with 1q21 amplification tend to have a poor prognosis. Ixazomib-bas
-
Application of acute isovolatic hemodilution techniques in cardiac surgery
Time of Update: 2022-10-14
Authors: Cai Chenghui, Zhao Liyun, Department of Anesthesiology, Beijing Anzhen Hospital-Beijing Institute of Cardiopulmonary and Vascular Diseases, Capital Medical University Postoperative bleeding i
-
Speech training combined with tDCS intervention in the analysis of the efficacy of children with language delay
Time of Update: 2022-10-02
【Research Conclusion】In summary, the traditional therapy combined with tDCS for the treatment of children's language development delay has a good clinical effect, which can significantly improve the child's language ability and oral motor function, improve the development status of the child, and deserve clinical promotion.
-
Availability of highly effective anticoagulant coating materials
Time of Update: 2022-10-02
The superhydrophilic properties of zwitterionic hydrogels and the excellent non-specific adsorption properties of anti-protein make them show great application prospects in the construction of anticoagulant coatings on the surface of blood contact devices.
-
Evonik launches non-animal collagen platform
Time of Update: 2022-09-24
Support in application, R&D and manufacturing services Evonik said that Vecollan is a new differentiated system solution specially designed by Evonik for the medical device industry, and is provided to customers through the Evonik Medical Device Technology Centers in Birmingham, Alabama, Darmstadt, Germany and Shanghai, China.
-
Experts and scholars: Make agricultural branding a strategic starting point for the revitalization of rural industries
Time of Update: 2022-09-07
" Jia Xiao, an agricultural branding expert and founder of Nongben Consulting, said straight to the point that the construction of regional public brands of agricultural products is a strategic starting point for rural revitalization, and has great potential in industrial development, resource integration, and value leadership.
-
DOM: Early and sustained stable glycemic control is associated with a reduction in major adverse cardiovascular events (MACE) in patients with type 2 diabetes
Time of Update: 2022-05-13
5%) (C to A transition) ) characteristics of people older than 12 monthsCONCLUSIONS: Early control of glycated hemoglobin improves cardiovascular outcomes in patients with type 2 diabetes, although subsequent glycemic changes have negative effects on the individual .
-
Disruption of the lung microbiome may explain why some children do poorly after stem cell transplants Science Translational Medicine
Time of Update: 2022-04-30
Click the blue text above to follow us A new study of 104 children finds that disruption of the lung microbiome may explain why some children with blood cancers and other blood diseases tend to have lower survival rates after stem cell transplants .
-
Cell Inspired by renowned cancer scientists: Immune cells leave traces on tumors that have metastasized to the brain
Time of Update: 2022-03-08
"Inspiration from renowned cancer researchers"Zena Werb was the first to see the potential and feasibility of collecting human metastases and combining it with cutting-edge technologies such as single-cell transcriptomics and cytology," Gonzalez said.
